Skip to main content
. 2017 May 9;8(31):51462–51477. doi: 10.18632/oncotarget.17721

Figure 6.

Figure 6

Figure 6

Silencing of the FoxO3a gene by siRNA prevents atrogin-1 upregulation (A) and BKCa β1 downregulation (B) in homocysteine-exposed PCASMCs. The role of atrogin-1 as a critical mediator of homocysteine-induced BKCa β1 loss is evidenced by the preserved protein level of BKCa β1 in homocysteine-exposed cells that are transfected with atrogin-1 siRNA (C). *p<0.05, **p<0.01; #p<0.05, ##p<0.01. Silencing of the FoxO3a gene prevents homocysteine-induced inhibition of BKCa channel currents (D & E). Original traces and I-V curves of whole-cell K+ current under unstimulated condition (D - left panel) and in response to NS1619 (E - left panel) in cells from different treatment groups before and after application of the BKCa channel blocker iberiotoxin. *p<0.05, **p<0.01, ***p<0.001 vs. basal, #p<0.05, ##p<0.01, ###p<0.001 NS1619+Ibtx vs. NS1619. Summarized data of BKCa channel currents from 5 independent experiments under conditions without (D - right panel) or with NS1619 stimulation. (E - lower panel), each obtained from cell isolates of different heart. *p<0.05. Hcy: homocysteine, Ibtx: iberiotoxin.